ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 94 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,040,000 | +98.3% | 750,000 | -12.5% | 0.35% | +130.7% |
| Q4 2019 | $1,029,000 | +36.3% | 857,311 | +71.5% | 0.15% | +13.3% |
| Q3 2019 | $755,000 | -62.4% | 500,000 | 0.0% | 0.14% | -53.8% |
| Q2 2019 | $2,010,000 | -6.5% | 500,000 | 0.0% | 0.29% | +9.4% |
| Q1 2019 | $2,150,000 | -25.2% | 500,000 | 0.0% | 0.27% | -41.2% |
| Q4 2018 | $2,875,000 | -29.3% | 500,000 | +66.7% | 0.45% | -6.8% |
| Q3 2018 | $4,068,000 | – | 300,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |